{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:12:25Z","timestamp":1781133145980,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovation Group Project of Shanghai Municipal Health Commission","award":["2019CXJQ03"],"award-info":[{"award-number":["2019CXJQ03"]}]},{"name":"Innovation Program of Shanghai Science and Technology Committee","award":["20Z11900300"],"award-info":[{"award-number":["20Z11900300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91640-6","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T14:51:09Z","timestamp":1740754269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An accurate DNA and RNA based targeted sequencing assay for clinical detection of gene fusions in solid tumors"],"prefix":"10.1038","volume":"15","author":[{"given":"Gang","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"91640_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/gcc.22335","volume":"55","author":"F Mertens","year":"2016","unstructured":"Mertens, F., Antonescu, C. R. & Mitelman, F. Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes. Genes Chromosomes Cancer. 55, 291\u2013310. https:\/\/doi.org\/10.1002\/gcc.22335 (2016).","journal-title":"Genes Chromosomes Cancer"},{"key":"91640_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrc2091","volume":"7","author":"F Mitelman","year":"2007","unstructured":"Mitelman, F., Johansson, B. & Mertens, F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer. 7, 233\u2013245. https:\/\/doi.org\/10.1038\/nrc2091 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"91640_CR3","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.5858\/arpa.2021-0230-OA","volume":"146","author":"Q Yao","year":"2022","unstructured":"Yao, Q. et al. Assessment of ALK fusions in uncommon inflammatory myofibroblastic tumors with ALK IHC positivity but FISH-Equivocal findings by targeted RNA sequencing. Arch. Pathol. Lab. Med. 146, 1234\u20131242. https:\/\/doi.org\/10.5858\/arpa.2021-0230-OA (2022).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"91640_CR4","doi-asserted-by":"publisher","first-page":"adv00180","DOI":"10.2340\/00015555-3542","volume":"100","author":"H Higaki-Mori","year":"2020","unstructured":"Higaki-Mori, H. et al. Infantile Lipofibromatosis-like neural tumour investigated by a fusion gene detection assay. Acta Derm. Venereol. 100, adv00180. https:\/\/doi.org\/10.2340\/00015555-3542 (2020).","journal-title":"Acta Derm Venereol."},{"key":"91640_CR5","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","volume":"363","author":"EL Kwak","year":"2010","unstructured":"Kwak, E. L. et al. Anaplastic lymphoma kinase Inhibition in non-small-cell lung cancer. N. Engl. J. Med. 363, 1693\u20131703. https:\/\/doi.org\/10.1056\/NEJMoa1006448 (2010).","journal-title":"N Engl. J. Med."},{"key":"91640_CR6","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1056\/NEJMc1404894","volume":"370","author":"AT Shaw","year":"2014","unstructured":"Shaw, A. T. & Engelman, J. A. Ceritinib in ALK-rearranged non-small-cell lung cancer. N. Engl. J. Med. 370, 2537\u20132539. https:\/\/doi.org\/10.1056\/NEJMc1404894 (2014).","journal-title":"N Engl. J. Med."},{"key":"91640_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S1470-2045(14)70362-6","volume":"15","author":"SM Gadgeel","year":"2014","unstructured":"Gadgeel, S. M. et al. Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1\/2 study. Lancet Oncol. 15, 1119\u20131128. https:\/\/doi.org\/10.1016\/S1470-2045(14)70362-6 (2014).","journal-title":"Lancet Oncol."},{"key":"91640_CR8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/annonc\/mdz131","volume":"30","author":"AT Shaw","year":"2019","unstructured":"Shaw, A. T. et al. Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): Updated results, including overall survival, from PROFILE 1001. Ann. Oncol. 30, 1121\u20131126. https:\/\/doi.org\/10.1093\/annonc\/mdz131 (2019).","journal-title":"Ann. Oncol."},{"key":"91640_CR9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1158\/2159-8290.CD-13-0035","volume":"3","author":"A Drilon","year":"2013","unstructured":"Drilon, A. et al. Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas. Cancer Discov. 3, 630\u2013635. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0035 (2013).","journal-title":"Cancer Discov"},{"key":"91640_CR10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1470-2045(18)30119-0","volume":"19","author":"TW Laetsch","year":"2018","unstructured":"Laetsch, T. W. et al. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: Phase 1 results from a multicentre, open-label, phase 1\/2 study. Lancet Oncol. 19, 705\u2013714. https:\/\/doi.org\/10.1016\/S1470-2045(18)30119-0 (2018).","journal-title":"Lancet Oncol."},{"key":"91640_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","volume":"21","author":"RC Doebele","year":"2020","unstructured":"Doebele, R. C. et al. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: Integrated analysis of three phase 1\u20132 trials. Lancet Oncol. 21, 271\u2013282. https:\/\/doi.org\/10.1016\/S1470-2045(19)30691-6 (2020).","journal-title":"Lancet Oncol."},{"key":"91640_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.pneumo.2018.09.013","volume":"74","author":"C Hamard","year":"2018","unstructured":"Hamard, C. et al. IHC, FISH, CISH, NGS in non-small cell lung cancer: What changes in the biomarker era? Rev. Pneumol Clin. 74, 327\u2013338. https:\/\/doi.org\/10.1016\/j.pneumo.2018.09.013 (2018).","journal-title":"Rev. Pneumol Clin."},{"key":"91640_CR13","doi-asserted-by":"publisher","first-page":"e17163","DOI":"10.1371\/journal.pone.0017163","volume":"6","author":"L Mittempergher","year":"2011","unstructured":"Mittempergher, L. et al. Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue. PLoS One. 6, e17163. https:\/\/doi.org\/10.1371\/journal.pone.0017163 (2011).","journal-title":"PLoS One"},{"key":"91640_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3760\/cma.j.cn112151-20221111-00946","volume":"52","author":"Molecular Pathology Collaboration Group of Tumor Pathology Committee of China Anti-Cancer","year":"2023","unstructured":"Molecular Pathology Collaboration Group of Tumor Pathology Committee of China Anti-Cancer. Chinese medical association Chinese society of, O. & pathology quality control, C. [Expert consensus on clinical practice of fusion genes detection in non-small cell lung cancer in China (2023 version)]. Zhonghua Bing Li Xue Za Zhi. 52, 565\u2013573. https:\/\/doi.org\/10.3760\/cma.j.cn112151-20221111-00946 (2023).","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"91640_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3779\/j.issn.1009-3419.2023.102.43","volume":"26","author":"D Precision","year":"2023","unstructured":"China Primary Health Care Foundation Tumor, Precision, D. & Treatment, C. Chinese Anti-Cancer association, L. C. S. G. O. C. O. O. [Chinese expert consensus O. the clinical practice O. Non-small cell lung Cancer fusion gene detection based O. RNA-based NGS]. Zhongguo Fei Ai Za Zhi. 26, 801\u2013812. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2023.102.43 (2023).","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"91640_CR16","doi-asserted-by":"publisher","first-page":"6351","DOI":"10.1038\/s41598-018-24781-6","volume":"8","author":"I Wimmer","year":"2018","unstructured":"Wimmer, I. et al. Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples. Sci. Rep. 8, 6351. https:\/\/doi.org\/10.1038\/s41598-018-24781-6 (2018).","journal-title":"Sci. Rep."},{"key":"91640_CR17","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1158\/1078-0432.CCR-19-0225","volume":"25","author":"R Benayed","year":"2019","unstructured":"Benayed, R. et al. High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden. Clin. Cancer Res. 25, 4712\u20134722. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0225 (2019).","journal-title":"Clin. Cancer Res."},{"key":"91640_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jtho.2020.10.156","volume":"16","author":"W Li","year":"2021","unstructured":"Li, W. et al. Potential unreliability of uncommon ALK, ROS1, and RET genomic breakpoints in predicting the efficacy of targeted therapy in NSCLC. J. Thorac. Oncol. 16, 404\u2013418. https:\/\/doi.org\/10.1016\/j.jtho.2020.10.156 (2021).","journal-title":"J. Thorac. Oncol."},{"key":"91640_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jmoldx.2021.12.004","volume":"24","author":"C Xiang","year":"2022","unstructured":"Xiang, C. et al. Identification and validation of noncanonical RET fusions in Non-Small-Cell lung Cancer through DNA and RNA sequencing. J. Mol. Diagn. 24, 374\u2013385. https:\/\/doi.org\/10.1016\/j.jmoldx.2021.12.004 (2022).","journal-title":"J. Mol. Diagn."},{"key":"91640_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/cjp2.208","volume":"7","author":"R Zhao","year":"2021","unstructured":"Zhao, R. et al. Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population. J. Pathol. Clin. Res. 7, 375\u2013384. https:\/\/doi.org\/10.1002\/cjp2.208 (2021).","journal-title":"J. Pathol. Clin. Res."},{"key":"91640_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jmoldx.2020.11.005","volume":"23","author":"H Peng","year":"2021","unstructured":"Peng, H. et al. Development and validation of an RNA sequencing assay for gene fusion detection in Formalin-Fixed, Paraffin-Embedded tumors. J. Mol. Diagn. 23, 223\u2013233. https:\/\/doi.org\/10.1016\/j.jmoldx.2020.11.005 (2021).","journal-title":"J. Mol. Diagn."},{"key":"91640_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00109-021-02149-0","volume":"100","author":"D Bergeron","year":"2022","unstructured":"Bergeron, D. et al. RNA-Seq for the detection of gene fusions in solid tumors: development and validation of the JAX fusionseq 2.0 assay. J. Mol. Med. (Berl). 100, 323\u2013335. https:\/\/doi.org\/10.1007\/s00109-021-02149-0 (2022).","journal-title":"J. Mol. Med. (Berl)"},{"key":"91640_CR23","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1111\/cas.15317","volume":"113","author":"W Hu","year":"2022","unstructured":"Hu, W. et al. Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma. Cancer Sci. 113, 1843\u20131854. https:\/\/doi.org\/10.1111\/cas.15317 (2022).","journal-title":"Cancer Sci."},{"key":"91640_CR24","doi-asserted-by":"publisher","first-page":"e1294","DOI":"10.1634\/theoncologist.2019-0236","volume":"24","author":"J Cao","year":"2019","unstructured":"Cao, J. et al. An accurate and comprehensive clinical sequencing assay for Cancer targeted and immunotherapies. Oncologist 24, e1294\u2013e1302. https:\/\/doi.org\/10.1634\/theoncologist.2019-0236 (2019).","journal-title":"Oncologist"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91640-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91640-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91640-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T14:51:17Z","timestamp":1740754277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91640-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91640"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91640-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7223"}}